Clinicians interested in use of exogenous estrogens and progestogens for the management of migraine can find these new European guidelines by clicking the following link: https://rdcu.be/5Cpq
Jointly published by the European Headache Federation and European Society of Contraception and Reproductive Health, they are evidence based.
This is the second guidance produced by this group – guidance on hormonal contraceptives and risk of ischemic stroke in women with migraine was published in 2018: https://link.springer.com/article/10.1186/s10194-017-0815-1